Invention Grant
- Patent Title: Forms of rifaximin and uses thereof
-
Application No.: US14580458Application Date: 2014-12-23
-
Publication No.: US09359357B2Publication Date: 2016-06-07
- Inventor: Karen S. Gushurst , Donglai Yang , Melanie Janelle Bevill , Nathan Carl Schultheiss , Giuseppe Claudio Viscomi
- Applicant: Karen S. Gushurst , Donglai Yang , Melanie Janelle Bevill , Nathan Carl Schultheiss , Giuseppe Claudio Viscomi
- Applicant Address: US NJ Bridgewater IT Bologna
- Assignee: Salix Pharmaceuticals, Ltd.,Alfa Wassermann S.P.A.
- Current Assignee: Salix Pharmaceuticals, Ltd.,Alfa Wassermann S.P.A.
- Current Assignee Address: US NJ Bridgewater IT Bologna
- Agency: McCarter & English, LLP
- Agent Jonathan M. Sparks; Michael J. DeGrazia
- Main IPC: C07D471/22
- IPC: C07D471/22 ; C07D498/16 ; C07D498/18

Abstract:
The present invention relates to Rifaximin amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.
Public/Granted literature
- US20150299199A1 FORMS OF RIFAXIMIN AND USES THEREOF Public/Granted day:2015-10-22
Information query